D-0321-2020 Class III Terminated

Recalled by Amneal Pharmaceuticals, Inc. — Brookhaven, NY

FDA drug recall D-0321-2020 was initiated by Amneal Pharmaceuticals, Inc. on Oct 16, 2019 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Tretinoin levels slightly above specification limits. The recall status is terminated (terminated Nov 9, 2020). Affected quantity: 2460 cartons/3 blister cards/10 capsules each.

Recall details

Product Type
Drugs
Report Date
Nov 20, 2019
Initiation Date
Oct 16, 2019
Termination Date
Nov 9, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2460 cartons/3 blister cards/10 capsules each

Product description

Isotretinoin Capsules, USP 10 mg. Rx Only, 3 Prescription Blister Packs of 10- Capsules Each (30 Capsules)-. Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC 69238-1174-3

Reason for recall

Failed Impurities/Degradation Specifications: Tretinoin levels slightly above specification limits.

Distribution pattern

Recalled product was distributed to retailers and wholesalers who may have further distribute the product.

Code information

Batch Numbers: BL10917, BL11017, BL11117, Exp. date 11/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0321-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0321-2020. Report a data issue: hello@regdatalab.com.